Skip to main content
OpenTrials
Completed

NCT Number: NCT05533684

A Single Preoperative Dose of Gabapentin to Decreases Postoperative Pain in Ambulatory Anal Surgeries

Single dose 600 mg gabapentin will be given preoperatively in anal surgeries

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain, Postoperative Neurologic Manifestations Pain Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Sarah Omar

Minya, 61111, Egypt

About this study

Patients will be grouped into 2 groups of 25 patients each, the first group will receive 600 mg of gabapentin one hour before surgery and the second group will receive a placebo tablet. pain scores will be measured postoperatively

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA physical status I or II
  • Aged from 18 to 65 years
  • Scheduled for anal surgeries at Minya University Hospital

Exclusion criteria

  • Presence of contraindications to neuraxial anesthesia
  • Presence of history of central nervous system or mental disorders, epilepsy, chronic pain, or drug abuse.
  • The use of neuropathic analgesic or antiepileptic drugs

Treatment and study plan

Gabapentin

Drug

single preoperative dose of 600 mg gabapentin

Other names: Gaptin 600 mg

Primary outcomes

  1. postoperative pain

    Time frame: first 12 hours postoperative

    measuring postoperative pain using the visual analog scale from 0 to 10, where zero is the least, and 10 is the worst pain

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Sep 9, 2022
Registry last updated
Mar 16, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.